Shintaro Nakano

1PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|May 09, 2022
Study protocol of the HGCSG1803: a phase II multicentre, non-randomised, single-arm, prospective trial of combination chemotherapy with oxaliplatin, irinotecan and S-1 (OX-IRIS) as first-line treatment for metastatic or relapsed pancreatic cancer.

Shintaro Nakano, Yasuyuki Kawamoto, Satoshi Yuki

Pageof 1

Frequent Collaborators

1 joint publications

Michio Nakamura

1 joint publications

Yoshito Komatsu